Evaluation of cryopreservation methods for a tissue-engineered artificial human oral mucosa model
ACTUALIDAD MEDICA · 30.04.2026 · 111 (822) · 9
DOI: 10.15568/am.2026.822.or01 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACTUALIDAD MEDICA, online erschienen am 30.04.2026. Verfasst von Silvia Aguilar-Pérez und 4 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Oral mucosa lesions may arise from a wide range of disorders, and their clinical management is largely based on grafting procedures However, the limited availability of oral mucosa and donor scarcity significantly restricts their application. Tissue Engineering emerges as a promising alternative, although the biofabrication of artificial oral mucosa requires long and complex production protocols. In this context, cryopreservation represents a potential strategy to enable large-scale manufacturing, long-term storage, and immediate availability of tissue-engineered constructs. The aim of this study is to evaluate the effect of different cryopreservation protocols on the cellular functionality of artificial human oral mucosa stroma. Stromal substitutes based on a fibrin–agarose matrix containing human gingival fibroblasts were cultured in vitro for 21 days and subsequently cryopreserved using four different cryoprotective solutions (10% DMSO, 10% glycerol, 0.35 M trehalose and CryoStor®) at different temperatures (4, −20, and −80 °C) for varying storage periods (7, 15, and 30 days). Non-cryopreserved constructs and constructs cryopreserved in a non-cryoprotective solution were used as controls. After thawing and reconditioning, four key aspects of cellular functionality were assessed: metabolic activity, proliferation, extracellular matrix remodeling and apoptotic activity, using WST-1, immunohistochemical and TUNEL assays. The results demonstrated that DMSO and CryoStor® cryoprotective solutions, when applied at freezing temperatures, more effectively preserved cellular metabolic activity, proliferative capacity, and matrix remodeling functions, while maintaining low levels of apoptosis-induced cell death. CryoStor® showed the most consistent protective performance, particularly at −80 °C. In contrast, trehalose yielded better outcomes at refrigeration temperature (4 °C), highlighting the strong temperature dependence of cryoprotective efficacy. Overall, these findings underscore the importance of optimizing cryopreservation protocols to ensure the functional preservation of tissue-engineered oral mucosa stromal substitutes, supporting their potential use as readily available products for clinical applications.
Zitieren
APA
Aguilar-Pérez, S., Egea-Marín, A., Chato-Astrain, J., Garzón, I., & Martín-Piedra, M. Á. (2026). Evaluation of cryopreservation methods for a tissue-engineered artificial human oral mucosa model. ACTUALIDAD MEDICA, 111(822), 9. https://doi.org/10.15568/am.2026.822.or01
Vancouver
Aguilar-Pérez S, Egea-Marín A, Chato-Astrain J, Garzón I, Martín-Piedra MÁ. Evaluation of cryopreservation methods for a tissue-engineered artificial human oral mucosa model. ACTUALIDAD MEDICA. 2026;111(822):9. doi:10.15568/am.2026.822.or01
BibTeX
@article{AguilarPrez2026,
author = {Aguilar-Pérez, Silvia and Egea-Marín, Antonia and Chato-Astrain, Jesús and Garzón, Ingrid and Martín-Piedra, Miguel Ángel},
title = {Evaluation of cryopreservation methods for a tissue-engineered artificial human oral mucosa model},
journal = {ACTUALIDAD MEDICA},
year = {2026},
volume = {111},
number = {822},
pages = {9},
doi = {10.15568/am.2026.822.or01}
}
EUVIMED